Nanotherapeutics for pulmonary drug delivery: An emerging approach to overcome respiratory diseases

E Kole, K Jadhav, N Shirsath, P Dudhe… - Journal of Drug Delivery …, 2023 - Elsevier
Pulmonary diseases pose an immense threat to global health. Several nanotherapeutics-
based approaches aimed to tackle pulmonary ailments in recent years. The current …

The role of particle physico-chemical properties in pulmonary drug delivery for tuberculosis therapy

NP Mortensen, P Durham, AJ Hickey - Journal of …, 2014 - Taylor & Francis
There is increasing interest in the use of inhaled aerosol drug therapy for the treatment of
tuberculosis (TB). A number of methods of preparation of particles have been employed …

A novel dry powder inhalable formulation incorporating three first-line anti-tubercular antibiotics

JGY Chan, HK Chan, CA Prestidge, JA Denman… - European Journal of …, 2013 - Elsevier
Treatment for tuberculosis (TB) using the standard oral antibiotic regimen is effective but
inefficient, requiring high drug dosing and lengthy treatment times. Three concurrent first-line …

Inhalable Particles Containing Rapamycin for Induction of Autophagy in Macrophages Infected with Mycobacterium tuberculosis

A Gupta, G Pant, K Mitra, J Madan… - Molecular …, 2014 - ACS Publications
We investigated whether particles suitable for delivery to alveolar macrophages may provide
a means of targeting rapamycin, an inducer of autophagy, to alveolar macrophages as a …

Fabrication of polyelectrolyte multilayered vesicles as inhalable dry powder for lung administration of rifampicin

ML Manca, D Valenti, OD Sales, A Nacher… - International journal of …, 2014 - Elsevier
A polyelectrolyte complex based on chitosan and carrageenan was used to coat rifampicin-
loaded vesicles and obtain a dry powder for inhalation by spray-drying. The polymer …

Composition influence on pulmonary delivery of rifampicin liposomes

ML Manca, C Sinico, AM Maccioni, O Diez, AM Fadda… - Pharmaceutics, 2012 - mdpi.com
The effects of lipid concentration and composition on the physicochemical properties,
aerosol performance and in vitro toxicity activity of several rifampicin-loaded liposomes were …

Isoniazid-gelatin conjugate microparticles containing rifampicin for the treatment of tuberculosis

ML Manca, R Cassano, D Valenti… - Journal of Pharmacy …, 2013 - academic.oup.com
Objectives In this work, a new polymeric microparticle system based on gelatin covalently
bound to isoniazid (ISN) and containing rifampicin (RFP) was prepared by spray-drying …

Inhalable particles containing isoniazid and rifabutin as adjunct therapy for safe, efficacious and relapse-free cure of experimental animal tuberculosis in one month

AK Singh, RK Verma, JK Mukker, AB Yadav, P Muttil… - Tuberculosis, 2021 - Elsevier
We investigated the preclinical efficacy and safety/tolerability of biodegradable polymeric
particles containing isoniazid (INH) and rifabutin (RFB) dry powder for inhalation (DPI) as an …

Foamy macrophage responses in the rat lung following exposure to inhaled pharmaceuticals: a simple, pragmatic approach for inhaled drug development

DJ Lewis, TC Williams, SL Beck - Journal of Applied …, 2014 - Wiley Online Library
Successes in the field of respiratory medicines are largely limited to three main target
classes: β2‐adrenergic receptor agonists, muscarinic antagonists and corticosteroids. A …

Preparation and characterization of controlled release poly-ɛ-caprolactone microparticles of isoniazid for drug delivery through pulmonary route

R Parikh, S Dalwadi - Powder technology, 2014 - Elsevier
In the present investigation inhaled isoniazid microparticles (IM) and isoniazid polymeric
microparticles (INH-PM) using poly-ɛ-caprolactone polymer were prepared through spray …